Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.
Carpentier A, Metellus P, Ursu R, Zohar S, Lafitte F, Barrié M, Meng Y, Richard M, Parizot C, Laigle-Donadey F, Gorochov G, Psimaras D, Sanson M, Tibi A, Chinot O, Carpentier AF. Carpentier A, et al. Among authors: zohar s. Neuro Oncol. 2010 Apr;12(4):401-8. doi: 10.1093/neuonc/nop047. Epub 2010 Jan 25. Neuro Oncol. 2010. PMID: 20308317 Free PMC article. Clinical Trial.
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.
Carpentier A, Laigle-Donadey F, Zohar S, Capelle L, Behin A, Tibi A, Martin-Duverneuil N, Sanson M, Lacomblez L, Taillibert S, Puybasset L, Van Effenterre R, Delattre JY, Carpentier AF. Carpentier A, et al. Among authors: zohar s. Neuro Oncol. 2006 Jan;8(1):60-6. doi: 10.1215/S1522851705000475. Neuro Oncol. 2006. PMID: 16443949 Free PMC article. Clinical Trial.
A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, Durand-Zaleski I, Ghez D, Dal Cortivo L, Piesvaux P, Cavazzana-Calvo M, Varet B. Lefrère F, et al. Among authors: zohar s. Haematologica. 2006 Apr;91(4):550-3. Haematologica. 2006. PMID: 16585020 Clinical Trial.
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients.
Lefrère F, Zohar S, Ghez D, Delarue R, Audat F, Suarez F, Hermine O, Damaj G, Maillard N, Ribeil JA, Azagury M, Misbahi R, Jondeau K, Cavazzana-Calvo M, Dal Cortivo L, Varet B. Lefrère F, et al. Among authors: zohar s. Bone Marrow Transplant. 2006 Apr;37(8):725-9. doi: 10.1038/sj.bmt.1705308. Bone Marrow Transplant. 2006. PMID: 16518433
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.
Lévy V, Zohar S, Bardin C, Vekhoff A, Chaoui D, Rio B, Legrand O, Sentenac S, Rousselot P, Raffoux E, Chast F, Chevret S, Marie JP. Lévy V, et al. Among authors: zohar s. Br J Cancer. 2006 Aug 7;95(3):253-9. doi: 10.1038/sj.bjc.6603265. Epub 2006 Jul 18. Br J Cancer. 2006. PMID: 16847470 Free PMC article. Clinical Trial.
150 results